文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

《嗜铬细胞瘤和副神经节瘤的诊断、遗传咨询和治疗的多学科实践指南》。

Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas.

机构信息

Medical Oncology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), UCM, CNIO, CIBERONC, Avda Cordoba km 5.4, 28041, Madrid, Spain.

Radiology Department, Hospital Clínico San Carlos, Madrid, Spain.

出版信息

Clin Transl Oncol. 2021 Oct;23(10):1995-2019. doi: 10.1007/s12094-021-02622-9. Epub 2021 May 6.


DOI:10.1007/s12094-021-02622-9
PMID:33959901
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8390422/
Abstract

Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors that arise from chromaffin cells of the adrenal medulla and the sympathetic/parasympathetic neural ganglia, respectively. The heterogeneity in its etiology makes PPGL diagnosis and treatment very complex. The aim of this article was to provide practical clinical guidelines for the diagnosis and treatment of PPGLs from a multidisciplinary perspective, with the involvement of the Spanish Societies of Endocrinology and Nutrition (SEEN), Medical Oncology (SEOM), Medical Radiology (SERAM), Nuclear Medicine and Molecular Imaging (SEMNIM), Otorhinolaryngology (SEORL), Pathology (SEAP), Radiation Oncology (SEOR), Surgery (AEC) and the Spanish National Cancer Research Center (CNIO). We will review the following topics: epidemiology; anatomy, pathology and molecular pathways; clinical presentation; hereditary predisposition syndromes and genetic counseling and testing; diagnostic procedures, including biochemical testing and imaging studies; treatment including catecholamine blockade, surgery, radiotherapy and radiometabolic therapy, systemic therapy, local ablative therapy and supportive care. Finally, we will provide follow-up recommendations.

摘要

嗜铬细胞瘤和副神经节瘤(PPGL)是罕见的神经内分泌肿瘤,分别起源于肾上腺髓质的嗜铬细胞和交感/副交感神经节。其病因的异质性使得 PPGL 的诊断和治疗非常复杂。本文的目的是从多学科的角度,涉及西班牙内分泌与营养学会(SEEN)、肿瘤医学学会(SEOM)、医学放射学会(SERAM)、核医学和分子影像学学会(SEMNIM)、耳鼻喉学会(SEORL)、病理学学会(SEAP)、放射肿瘤学会(SEOR)、外科学会(AEC)和西班牙国家癌症研究中心(CNIO),为 PPGL 的诊断和治疗提供实用的临床指南。我们将回顾以下主题:流行病学;解剖、病理和分子途径;临床表现;遗传易感性综合征和遗传咨询与检测;包括生化检测和影像学研究在内的诊断程序;治疗包括儿茶酚胺阻断、手术、放疗和放代谢治疗、系统治疗、局部消融治疗和支持性护理。最后,我们将提供随访建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0a3/8390422/978ec45f0f31/12094_2021_2622_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0a3/8390422/777599df5abc/12094_2021_2622_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0a3/8390422/1f0cb6215e30/12094_2021_2622_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0a3/8390422/978ec45f0f31/12094_2021_2622_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0a3/8390422/777599df5abc/12094_2021_2622_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0a3/8390422/1f0cb6215e30/12094_2021_2622_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0a3/8390422/978ec45f0f31/12094_2021_2622_Fig3_HTML.jpg

相似文献

[1]
Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas.

Clin Transl Oncol. 2021-10

[2]
Diagnosis and Management of Pheochromocytomas and Paragangliomas: A Guide for the Clinician.

Endocr Pract. 2023-12

[3]
[Phaeochromocytoma and paraganglioma].

Rev Med Interne. 2019-11

[4]
Pheochromocytoma and paraganglioma: imaging characteristics.

Cancer Imaging. 2012-5-7

[5]
Pheochromocytoma and paraganglioma-an update on diagnosis, evaluation, and management.

Pediatr Nephrol. 2020-4

[6]
The Pheochromocytoma/Paraganglioma syndrome: an overview on mechanisms, diagnosis and management.

Int Braz J Urol. 2023

[7]
[Pheochromocytoma and paraganglioma: basics for the general practitioner].

Rev Med Suisse. 2014-9-10

[8]
Challenges in Paragangliomas and Pheochromocytomas: from Histology to Molecular Immunohistochemistry.

Endocr Pathol. 2021-6

[9]
Emerging molecular markers of metastatic pheochromocytomas and paragangliomas.

Ann Endocrinol (Paris). 2019-4-11

[10]
Hereditary pheochromocytoma and paraganglioma.

J Surg Oncol. 2012-5-30

引用本文的文献

[1]
Treatment with radiotherapy in carotidal paraganglioma: experience of the General Hospital of Mexico.

Rep Pract Oncol Radiother. 2025-8-7

[2]
Update of the guidelines on the management of adrenal incidentaloma from the adrenal group of the Spanish society of endocrinology and nutrition (SEEN).

Endocrine. 2025-9-4

[3]
Advancements and Challenges in the Preoperative Management of Pheochromocytoma in a Low- and Middle-Income Country (LMIC): A Nationwide Survey.

Cureus. 2025-7-31

[4]
Late Onset Malignant Metastatic Transformation of Benign Pheochromocytoma.

J Community Hosp Intern Med Perspect. 2025-7-3

[5]
Functional paraganglioma of the pancreatic head: A case report and review of literature.

World J Gastrointest Surg. 2025-7-27

[6]
CT features predict tumour invasion of adrenal pheochromocytoma: a retrospective observational study.

BMC Med Imaging. 2025-7-14

[7]
Global epidemiology of pheochromocytoma: a systematic review and meta-analysis of observational studies.

J Endocrinol Invest. 2025-7-2

[8]
Prognostic markers in pheochromocytomas/paragangliomas: the role of histopathology, SDHB, MAML3 and MCM6 expression.

J Endocrinol Invest. 2025-5-30

[9]
CT-based radiomics deep learning signatures for non-invasive prediction of metastatic potential in pheochromocytoma and paraganglioma: a multicohort study.

Insights Imaging. 2025-4-5

[10]
Current Strategies for Managing Pheochromocytoma and Paraganglioma in Children and Adolescents.

Med Sci Monit. 2025-4-3

本文引用的文献

[1]
What Have We Learned from Molecular Biology of Paragangliomas and Pheochromocytomas?

Endocr Pathol. 2021-3

[2]
Epidemiology of pheochromocytoma and paraganglioma: population-based cohort study.

Eur J Endocrinol. 2021-1

[3]
Genetic stratification of inherited and sporadic phaeochromocytoma and paraganglioma: implications for precision medicine.

Hum Mol Genet. 2020-10-20

[4]
Approach to the Patient: Perioperative Management of the Patient with Pheochromocytoma or Sympathetic Paraganglioma.

J Clin Endocrinol Metab. 2020-9-1

[5]
A review of the tumour spectrum of germline succinate dehydrogenase gene mutations: Beyond phaeochromocytoma and paraganglioma.

Clin Endocrinol (Oxf). 2020-11

[6]
Clinical characteristics and outcomes of SDHB-related pheochromocytoma and paraganglioma in children and adolescents.

J Cancer Res Clin Oncol. 2020-2-15

[7]
Current Management of Pheochromocytoma/Paraganglioma: A Guide for the Practicing Clinician in the Era of Precision Medicine.

Cancers (Basel). 2019-10-8

[8]
The use of telemedicine in the preoperative management of pheochromocytoma saves resources.

Mhealth. 2019-8-20

[9]
Pheochromocytoma and Paraganglioma.

N Engl J Med. 2019-8-8

[10]
Pheochromocytoma and paraganglioma: clinical feature-based disease probability in relation to catecholamine biochemistry and reason for disease suspicion.

Eur J Endocrinol. 2019-10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索